Creation of a Small Cavity Reduces the Rate of Cement Leakage During Vertebral Body Augmentation

NCT ID: NCT02557113

Last Updated: 2015-09-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-01-31

Study Completion Date

2013-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Leakage of polymethylmethacrylate (PMMA) is the most common complication during vertebral body augmentation and can lead to serious patient morbidity. Any measure to reduce the rate of cement leakage is of value and makes the procedure safer.The aim of this study was to investigate the effect of the creation of a cavity on cement leakage during vertebroplasty. Investigators tested the hypothesis that the creation of a merely small and irregular cavity in vertebral body prior to cement injection would reduce cement leakage.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vertebral Body Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vertebroplasty

This Group Underwent the Vertebroplasty Procedure (Injection of Bone Cement into the Fractured Osteoporotic Vertebral Body)

Group Type ACTIVE_COMPARATOR

Vertebroplasty

Intervention Type PROCEDURE

Fractured Osteoporotic Vertebral Body is Augmented with Injection of Bone Cement

Cavuplasty

This Group Underwent the Cavuplasty Procedure (Small Cavity was Created in the Vertebral Body Prior to Injection of Bone Cement)

Group Type EXPERIMENTAL

Cavuplasty

Intervention Type PROCEDURE

Small Cavity is Created in Fractured Osteoporotic Vertebral Body Prior to Cement Injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vertebroplasty

Fractured Osteoporotic Vertebral Body is Augmented with Injection of Bone Cement

Intervention Type PROCEDURE

Cavuplasty

Small Cavity is Created in Fractured Osteoporotic Vertebral Body Prior to Cement Injection

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Osteoporotic vertebral body fractures of the thoracolumbar spine (T9 to L4) that were classified as A1 fractures according to Arbeitsgemeinschaft Osteosynthesis (AO) Classification

Exclusion Criteria

* More Than 2 Vertebral Body Fractures
* Fractures of Vertebral Body Based on Malignancy
* Previous Spinal Operation
* Spinal Infection
* Spinal Deformity (scoliosis)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mohammad ARAB MOTLAGH

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohammad ARAB MOTLAGH

Dr. med.

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohammad Arab Motlagh, MD

Role: STUDY_DIRECTOR

Department of Orthopaedic Surgery University Hospital Frankfurt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Cavuplasty

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cervical Spondylotic Myelopathy Surgical Trial
NCT02076113 ACTIVE_NOT_RECRUITING NA
Lumbar Fusion With Porous Versus Non-Porous Cages
NCT05583864 ACTIVE_NOT_RECRUITING NA
Natural Matrix Protein
NCT07217964 ENROLLING_BY_INVITATION